Physician profile
Paul Rebenack
NPI 1457312738
$3,752.27
in general payments reported to CMS, 2019-2025
28 companies · $415 in 2025
The $415 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,675 · 2020: $168 · 2021: $339 · 2022: $305 · 2023: $583 · 2024: $266 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $850.19 | 2019 | |
| Abbvie INC. | $482.11 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $327.99 | 2019-2025 | |
| Astellas Pharma US INC | $248.60 | 2023-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $228.28 | 2021-2023 | Phexxi |
| Mayne Pharma Commercial LLC | $204.83 | 2021-2025 | |
| Sage Therapeutics, LLC | $204.77 | 2021-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $171.70 | 2023-2024 | Myfembree |
| Lupin INC. | $129.62 | 2019-2020 | |
| Hologic Sales and Service, LLC | $118.58 | 2020-2021 | |
| Organon LLC | $98.85 | 2021-2024 | Nexplanon |
| Minerva Surgical, INC | $96.82 | 2019-2025 | |
| Exact Sciences Corporation | $94.06 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $87.97 | 2019-2024 | |
| Myriad Women'S Health, INC. | $63.81 | 2023 | Myrisk |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $59.56 | 2019-2022 | |
| Millicent US INC | $51.49 | 2024-2025 | Intrarosa, Femring |
| Optumhealth Care Solutions, LLC | $37.98 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Merck Sharp & Dohme LLC | $25.65 | 2019 | |
| Amag Pharmaceuticals, INC. | $25.52 | 2019-2020 | |
| Shield Therapeutics INC | $24.58 | 2023 | Accrufer |
| Duchesnay USA Incorporated | $20.09 | 2019 | |
| Daiichi Sankyo INC. | $19.90 | 2019 | |
| Olympus America INC. | $18.21 | 2023 | Endoeye Flex 3d Deflectable Videoscope, Olympus, Pneumoliner |
| Exeltis, USA INC. | $16.43 | 2024 | Slynd |
| Avanos Medical | $15.80 | 2019 | |
| Avion Pharmaceuticals | $14.89 | 2019 | |
| Allergan, INC. | $13.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Rebenack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.